James J. Collins - Director at Fulcrum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
FULC on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James J. Collins since 07 Feb 2025

Holdings reported by James J. Collins for Fulcrum Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 30,000 17 Jun 2024 Direct Common Stock

Transactions reported by James J. Collins for Fulcrum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.